Type 2 diabetes mellitus (T2DM) is the most common type of diabetes, making up approximately 90% of the total number of patients with diabetes in high-income countries, with an estimated 415 million adults with diabetes worldwide in 2015 [2]
As a result, the FDA has issued guidance for compounding pharmacies to help address the shortage by making essential copies of the patented drugs, for as long as the drugs remain on the FDAs Shortage List
Ongoing Monitoring Post-Approval: After approval, the FDA continues to monitor the drug through post-market surveillance
In Wellington, Florida and Traverse City, Michigan, RegenCen patients receive in-person, physician-supervised semaglutide treatment customized to their body composition, lifestyle, and long-term health goals
Semaglutide is retailed under the brand names Ozempic and Wegovy, feeding to different requirements for diabetes operation and weight loss
Patients with diabetes are already at higher risk for vascular complications, he continued, and any additional factors that could affect blood flow to the optic nerve might increase the risk of NAION. Another theory involves the mechanism by which semaglutide works
